Last reviewed · How we verify
intermittent preventive treatment
intermittent preventive treatment is a Small molecule drug developed by London School of Hygiene and Tropical Medicine. It is currently in Phase 2 development. Also known as: SP, Du-Cotecxin.
At a glance
| Generic name | intermittent preventive treatment |
|---|---|
| Also known as | SP, Du-Cotecxin |
| Sponsor | London School of Hygiene and Tropical Medicine |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Improving Care Through Azithromycin Research for Infants in Africa (PHASE3)
- A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine (PHASE3)
- The PROTECT 2 Study : Pressure Injury Treatment by Intermittent Electrical Stimulation: A Randomized, Controlled Trial (NA)
- Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 (PHASE2)
- Evaluating the SWW Method Dietary Intervention for HbA1c and Weight Management as a Preventative Intervention in Women (NA)
- Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
- Tell Me More ("Dime Mas") (NA)
- Prophylactic Use of APRV Before Extubation in Morbidly Obese Patients After Cardiac Surgery. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- intermittent preventive treatment CI brief — competitive landscape report
- intermittent preventive treatment updates RSS · CI watch RSS
- London School of Hygiene and Tropical Medicine portfolio CI
Frequently asked questions about intermittent preventive treatment
What is intermittent preventive treatment?
intermittent preventive treatment is a Small molecule drug developed by London School of Hygiene and Tropical Medicine.
Who makes intermittent preventive treatment?
intermittent preventive treatment is developed by London School of Hygiene and Tropical Medicine (see full London School of Hygiene and Tropical Medicine pipeline at /company/london-school-of-hygiene-and-tropical-medicine).
Is intermittent preventive treatment also known as anything else?
intermittent preventive treatment is also known as SP, Du-Cotecxin.
What development phase is intermittent preventive treatment in?
intermittent preventive treatment is in Phase 2.
Related
- Manufacturer: London School of Hygiene and Tropical Medicine — full pipeline
- Also known as: SP, Du-Cotecxin
- Compare: intermittent preventive treatment vs similar drugs
- Pricing: intermittent preventive treatment cost, discount & access